DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

July 20, 2017

CANNABINOIDS: Potential AntiCancer Agents

Our visit with Dr. Nephi Stella at the University of Washington on July 19th, 2017 was fascinating and we wanted to share some of the information with you!

Ultimately, research suggests that cannabinoids molecules with a chemical structure similar to the marijuana component THC can affect neuroinflammation. Consequently, Dr. Stella is currently investigating whether cannabinoids affect the interactions among neurons, astrocytes, and microglia that occur during uncontrolled neuroinflammatory responses.

Additionally, his lab group is currently testing whether agents acting through cannabinoid CB2 receptors can boost the immune system against brain tumors or temper the autoimmune response associated with multiple sclerosis.

The goal of this research project is to identify cannabinoid agents that will provide treatment of diverse neuropathologies while being devoid of psychotropic and abuse properties.

It is, therefore, exciting to think about what the future might hold for medical marijuana. For example, could it be the case that Green Health Docs Missouri could soon be prescribing marijuana to combat brain tumors? In states like Missouri where marijuana has been legalized, cannabis is being used to manage a wide range of health complaints relating to the brain such as anxiety, depression, and chronic pain.

Here is a little bit more about what we learned…

  • Application for use in cancer for both symptom management and potential cancer cell death. The lab learned that CBD does kill cancer cells, just not very efficiently. They have created a purely synthetic version of CBD, which is approximately 300 times stronger. There are excellent results in mouse models with this agent. Dr. Stella anticipates a phase I human subjects trial opening in approximately 2 years. This is a very exciting development in his work and passion of the past 17 years!
  • CBD kills cancer cells by disrupting the micro-tubules in the tumor cell, preventing cells from dividing.
  • Cannabidiol (CBD) is the medicinal, non-psychotropic component of the marijuana plant.
  • Delta-9 THC is the recreational, plant-based component

After learning about the properties of CBD, you might want to try some CBD products to see for yourself how your health can benefit. Do not be afraid to shop around to find the right CBD products for your needs.

Read Manuel Guzman’s detailed report here…Canaboids- Potential Anticancer

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram